|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 146.20 INR | +1.32% |
|
-2.14% | +77.75% |
| 05-22 | IOL Chemicals and Pharmaceuticals Limited, Q4 2026 Earnings Call, May 22, 2026 | |
| 05-20 | IOL Chemicals and Pharmaceuticals March-quarter consol profit 531.6 million rupees | RE |
| Market Cap | 42.91B 450M 391M 364M 334M 631M 640M 4.29B 1.68B 21.36B 1.69B 1.65B 71.64B | P/E 2026 |
15.5x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 42.91B 450M 391M 364M 334M 631M 640M 4.29B 1.68B 21.36B 1.69B 1.65B 71.64B | EV / Sales 2026 |
0.92x | EV / Sales 2027 * | - |
| Free-Float |
33.91% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: IOL Chemicals and Pharmaceuticals Limited
| 1 day | +1.32% | ||
| 1 week | -2.14% | ||
| 1 month | -0.71% | ||
| 3 months | +55.20% | ||
| 6 months | +99.24% | ||
| Current year | +77.75% |
| 1 week | 143.55 | 152.9 | |
| 1 month | 140.45 | 179.65 | |
| Current year | 67.14 | 179.65 | |
| 1 year | 67.14 | 179.65 | |
| 3 years | 57.51 | 179.65 | |
| 5 years | 54.44 | 179.65 | |
| 10 years | 8.4 | 179.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | 34 | - |
Pardeep Khanna
DFI | Director of Finance/CFO | - | - |
Abhay Raj Singh
CMP | Compliance Officer | - | 13/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Varinder Gupta
CHM | Chairman | 63 | 31/08/2007 |
Vikas Gupta
BRD | Director/Board Member | 34 | 28/05/2015 |
| Chairman | 73 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.32% | -2.14% | +45.76% | +86.41% | 450M | ||
| -0.53% | -3.95% | +50.70% | +153.56% | 1,024B | ||
| +0.21% | -2.68% | +53.20% | +51.79% | 618B | ||
| -2.51% | -3.25% | +28.54% | +68.94% | 443B | ||
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | ||
| -0.69% | -0.30% | +13.76% | +12.83% | 264B | ||
| -7.37% | -4.40% | -0.74% | -44.28% | 209B | ||
| -0.64% | +2.43% | +29.74% | +65.93% | 208B | ||
| -0.82% | +0.70% | +15.05% | +72.05% | 162B | ||
| +0.40% | +1.92% | +6.47% | -29.77% | 143B | ||
| Average | -1.06% | -1.31% | +28.00% | +46.81% | 341.94B | |
| Weighted average by Cap. | -1.00% | -2.02% | +36.14% | +71.90% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 23.04B 241M 210M 195M 179M 339M 344M 2.3B 903M 11.47B 906M 886M 38.45B | - |
| Net income | 1.3B 13.58M 11.8M 10.98M 10.09M 19.05M 19.34M 129M 50.82M 645M 50.99M 49.87M 2.16B | - |
| Net Debt | - | - |
Employees
2,891
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | ₹146.20 | +1.32% | 82,932 |
| 30/07/26 | ₹144.30 | -2.20% | 80,726 |
| 29/07/26 | ₹147.55 | +0.37% | 102,004 |
| 28/07/26 | ₹147.00 | -3.10% | 98,517 |
| 27/07/26 | ₹151.70 | +1.54% | 124,014 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
146.20INR
Average target price
150.00INR
Spread / Average Target
+2.60%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IOLCP Stock
Select your edition
All financial news and data tailored to specific country editions

















